Printer Friendly
The Free Library
19,604,540 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CRF Inc.: eDiary Patent Infringement Lawsuits Cleared.


WALTHAM, Mass. -- CRF CRF
abbr.
chronic renal failure


CRF Chronic renal failure
 Inc., the world leader in electronic Patient Reported Outcomes (e-PRO) and wireless data collection solutions for the biopharmaceutical industry, today confirmed that its has reached a settlement with PHT PHT Phenytoin (antiepileptic, Dilantin)
PHT Pulmonary Hypertension
PhT Pharmacy Technician
PHT Post-Harvest Technology
PHT Pattern History Table
PHT Pressure Half Time
PHT Public Health Trust
 Corp. related to the patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver.  lawsuit lawsuit: see procedure; tort.  filed by PHT in January 2004. Terms of the settlement are confidential, but CRF has been granted a fully paid up, worldwide license under the PHT-licensed patents and CRF's business tort tort, in law, the violation of some duty clearly set by law, not by a specific agreement between two parties, as in breach of contract. When such a duty is breached, the injured party has the right to institute suit for compensatory damages.  counterclaims have been dismissed.

"We are very pleased with this settlement," said Pam McNamara, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of CRF. "Putting these lawsuits behind us is a win for the whole eDiary sector. We are now all able to fully focus our efforts on growing our industry and meeting the needs of our pharmaceutical clients, clinical sites and patients around the world."

About CRF Inc.

CRF Inc. is the leading global provider of electronic Patient Reported Outcomes (e-PRO) and wireless data collection solutions for the biopharmaceutical industry. Through innovative technology and a thorough understanding of drug development and mobile computing Using a computing device while in transit. Mobile computing implies wireless transmission, but wireless transmission does not necessarily imply mobile computing. Fixed wireless applications use satellites, radio systems and lasers to transmit between permanent objects such as buildings , the company is driving the change to safer and more efficient paper-free clinical trials. CRF Inc.'s technology has been used by more than 100,000 patients across 58 countries in 57 languages for 32 indications. The company has demonstrated the industry's highest patient compliance rates -- an average 95 percent compliance through Phase I, II, III and IV clinical trials -- and unmatched patient and research site acceptance.

CRF Inc.'s award-winning product, TrialMax(TM), is a flexible and customizable e-PRO technology that provides real-time patient monitoring, outstanding data accuracy and increased safety. Its unique features enable clinical trial sponsors to collect more valuable data faster and conduct complex clinical trials with greater flexibility than other e-PRO solutions. CRF Inc.'s experience combined with its dedication to ensuring the highest quality and most responsive customer service has made the company the biopharmaceutical industry's most trusted partner.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 4, 2006
Words:312
Previous Article:GlowPoint Issues $5.65 Million in Senior Secured Convertible Notes in Private Placement; Proceeds to Support Corporate Restructuring Program and...
Next Article:STRATEGY ANALYTICS: North American Cellular EBITDA Surges 30 Percent in Q4 2005; New Research Finds Q4 EBITDA Margins at Decade High.
Topics:



Related Articles
SEAGATE FILES PATENT LAWSUIT AGAINST STORAGE COMPUTER CORP.
SCOOTER MAKERS SKATING ON THIN ICE, SUIT CLAIMS PATENT INFRINGEMENT CITED.
3D EXEC SAYS COURT DAMAGES WON'T BE LARGE.
Speedline and EKRA enter legal battle.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles